BFC Planning, Inc.’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.22M Buy
41,182
+1,164
+3% +$93.9K 0.13% 166
2026
Q1
$3.47M Sell
40,018
-63,316
-61% -$6.07M 0.15% 135
2025
Q4
$9.9M Buy
103,334
+99,586
+2,657% +$9.7M 0.44% 42
2025
Q3
$357K Sell
3,748
-66
-2% -$6.07K 0.03% 479
2025
Q2
$333K Sell
3,814
-1,827
-32% -$155K 0.03% 458
2025
Q1
$507K Buy
5,641
+56
+1% +$5.01K 0.04% 328
2024
Q4
$446K Buy
+5,585
New +$483K 0.04% 361

Other funds holding MDT

BFC Planning, Inc.'s MDT Position: Q2 2026 in Review

BFC Planning, Inc. increased its Medtronic (MDT) stake by 2.9% in Q2 2026, buying an estimated $93.9K and bringing the position to 41,182 shares worth $3.22M. The position accounts for 0.13% of the portfolio, ranked #166.

BFC Planning, Inc. first reported a position in MDT in Q4 2024 and has held it in 7 quarters since. The position peaked at $9.9M in Q4 2025. 2,151 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • BFC Planning, Inc. held 41,182 shares of Medtronic worth $3.22M as of Q2 2026.
  • BFC Planning, Inc. bought 1,164 Medtronic shares in Q2 2026, an estimated $93.9K.
  • Medtronic made up 0.13% of BFC Planning, Inc.'s portfolio in Q2 2026, its #166 holding.
  • BFC Planning, Inc. first reported a position in Medtronic in Q4 2024 and has held it in 7 quarters since.
  • BFC Planning, Inc.'s Medtronic position peaked at $9.9M in Q4 2025.
  • 2,151 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on BFC Planning, Inc.'s 13F filing for Q2 2026, filed 29 Oct 2026.